447 related articles for article (PubMed ID: 22476980)
1. Natural inhibitors of poly(ADP-ribose) polymerase-1.
Banasik M; Stedeford T; Strosznajder RP
Mol Neurobiol; 2012 Aug; 46(1):55-63. PubMed ID: 22476980
[TBL] [Abstract][Full Text] [Related]
2. Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.
Henning RJ; Bourgeois M; Harbison RD
Cardiovasc Toxicol; 2018 Dec; 18(6):493-506. PubMed ID: 29968072
[TBL] [Abstract][Full Text] [Related]
3. Structure and function of poly(ADP-ribose) polymerase-1: role in oxidative stress-related pathologies.
Virág L
Curr Vasc Pharmacol; 2005 Jul; 3(3):209-14. PubMed ID: 16026317
[TBL] [Abstract][Full Text] [Related]
4. Poly (adp-ribose) polymerase inhibitors as potential therapeutic agents in stroke and neurotrauma.
Komjáti K; Besson VC; Szabó C
Curr Drug Targets CNS Neurol Disord; 2005 Apr; 4(2):179-94. PubMed ID: 15857303
[TBL] [Abstract][Full Text] [Related]
5. The therapeutic potential of poly(ADP-ribose) polymerase inhibitors.
Virág L; Szabó C
Pharmacol Rev; 2002 Sep; 54(3):375-429. PubMed ID: 12223530
[TBL] [Abstract][Full Text] [Related]
6. Identifying Direct Protein Targets of Poly-ADP-Ribose Polymerases (PARPs) Using Engineered PARP Variants-Orthogonal Nicotinamide Adenine Dinucleotide (NAD+) Analog Pairs.
Carter-O'Connell I; Cohen MS
Curr Protoc Chem Biol; 2015 Jun; 7(2):121-39. PubMed ID: 26344237
[TBL] [Abstract][Full Text] [Related]
7. Poly(ADP-ribose) polymerase inhibitors.
Southan GJ; Szabó C
Curr Med Chem; 2003 Feb; 10(4):321-40. PubMed ID: 12570705
[TBL] [Abstract][Full Text] [Related]
8. Poly(ADP-ribose) polymerase as a key player in excitotoxicity and post-ischemic brain damage.
Meli E; Pangallo M; Baronti R; Chiarugi A; Cozzi A; Pellegrini-Giampietro DE; Moroni F
Toxicol Lett; 2003 Apr; 139(2-3):153-62. PubMed ID: 12628750
[TBL] [Abstract][Full Text] [Related]
9. Alternative mechanisms of inhibiting activity of poly (ADP-ribose) polymerase-1.
Sriram CS; Jangra A; Bezbaruah BK; V AK; Sykam S
Front Biosci (Schol Ed); 2016 Jan; 8(1):123-8. PubMed ID: 26709902
[TBL] [Abstract][Full Text] [Related]
10. Poly(ADP-ribose) polymerase inhibitors: new pharmacological functions and potential clinical implications.
de la Lastra CA; Villegas I; Sánchez-Fidalgo S
Curr Pharm Des; 2007; 13(9):933-62. PubMed ID: 17430191
[TBL] [Abstract][Full Text] [Related]
11. Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase.
Endres M; Wang ZQ; Namura S; Waeber C; Moskowitz MA
J Cereb Blood Flow Metab; 1997 Nov; 17(11):1143-51. PubMed ID: 9390645
[TBL] [Abstract][Full Text] [Related]
12. Review of poly (ADP-ribose) polymerase (PARP) mechanisms of action and rationale for targeting in cancer and other diseases.
Morales J; Li L; Fattah FJ; Dong Y; Bey EA; Patel M; Gao J; Boothman DA
Crit Rev Eukaryot Gene Expr; 2014; 24(1):15-28. PubMed ID: 24579667
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms governing PARP expression, localization, and activity in cells.
Sanderson DJ; Cohen MS
Crit Rev Biochem Mol Biol; 2020 Dec; 55(6):541-554. PubMed ID: 32962438
[TBL] [Abstract][Full Text] [Related]
14. Poly (ADP-ribose) polymerase: An Overview of Mechanistic Approaches and Therapeutic Opportunities in the Management of Stroke.
Tiwari P; Khan H; Singh TG; Grewal AK
Neurochem Res; 2022 Jul; 47(7):1830-1852. PubMed ID: 35437712
[TBL] [Abstract][Full Text] [Related]
15. A novel and potent poly(ADP-ribose) polymerase-1 inhibitor, FR247304 (5-chloro-2-[3-(4-phenyl-3,6-dihydro-1(2H)-pyridinyl)propyl]-4(3H)-quinazolinone), attenuates neuronal damage in in vitro and in vivo models of cerebral ischemia.
Iwashita A; Tojo N; Matsuura S; Yamazaki S; Kamijo K; Ishida J; Yamamoto H; Hattori K; Matsuoka N; Mutoh S
J Pharmacol Exp Ther; 2004 Aug; 310(2):425-36. PubMed ID: 15075382
[TBL] [Abstract][Full Text] [Related]
16. Poly(ADP-Ribose) polymerase-1 in acute neuronal death and inflammation: a strategy for neuroprotection.
Skaper SD
Ann N Y Acad Sci; 2003 May; 993():217-28; discussion 287-8. PubMed ID: 12853316
[TBL] [Abstract][Full Text] [Related]
17. Using Clickable NAD
Zhang L; Lin H
Methods Mol Biol; 2017; 1608():95-109. PubMed ID: 28695506
[TBL] [Abstract][Full Text] [Related]
18. Poly ADP-ribose polymerase-1 and health.
Kirkland JB
Exp Biol Med (Maywood); 2010 May; 235(5):561-8. PubMed ID: 20463295
[TBL] [Abstract][Full Text] [Related]
19. Poly (ADP-ribose) polymerase, nitric oxide and cell death.
Pieper AA; Verma A; Zhang J; Snyder SH
Trends Pharmacol Sci; 1999 Apr; 20(4):171-81. PubMed ID: 10322503
[TBL] [Abstract][Full Text] [Related]
20. Poly(ADP-ribose) polymerase-1 activity promotes NF-kappaB-driven transcription and microglial activation: implication for neurodegenerative disorders.
Chiarugi A; Moskowitz MA
J Neurochem; 2003 Apr; 85(2):306-17. PubMed ID: 12675907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
